{"id":403181,"date":"2020-12-18T19:09:49","date_gmt":"2020-12-19T00:09:49","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403181"},"modified":"2020-12-18T19:09:49","modified_gmt":"2020-12-19T00:09:49","slug":"beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/","title":{"rendered":"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, Dec.  18, 2020  (GLOBE NEWSWIRE) &#8212; Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT)\u00a0breached their fiduciary duties in connection with the proposed sale of the Company to Royal Philips (NYSE: PHG, AEX: PHIA).<\/p>\n<p align=\"start\">On December 18, 2020, BioTelemetry announced that it had entered into a definitive merger agreement with Royal Philips. Under the terms of the acquisition agreement, the Company&#8217;s shareholders will receive $72.00 per share in cash.<\/p>\n<p align=\"start\">The investigation concerns whether the BioTelemetry board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for BioTelemetry shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given analysts&#8217; projections for future earnings and revenue growth. Additionally, one Wall Street analyst had a $77.00 price target on the stock.<\/p>\n<p align=\"start\">If you are a shareholder of BioTelemetry and believe the proposed buyout price is too low or you&#8217;re interested in learning more about the investigation, please contact lead analyst Jim Baker (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HTZmyD6jYgW8eiaz_U9slJCxSjLJ6-4wrI18frvTHO3zgz2hxzRfDvLEg7ZGR6FMKQyIO0xo4YhcyV1t4Do66h0gRGSlIzaO_9tgMWFKq2o=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>jimb@johnsonfistel.com<\/u><\/a>) at <u>619-814-4471<\/u>.\u00a0If emailing, please include a phone number.<\/p>\n<p align=\"start\">Additionally, you can [<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_qlav5TEXtmBN8tHNAUyEvt-ftSHDCp7DiRgb39Dgma90T6of8elN6g5Ou-hV61TAaGfNbKzRDbFdzeVSV78Yt0TBKvqiCMrx6T1Z3YnB9-rFyWLEkfvex69AytmJgNBUA9Dqwym3lArPma7wCZbyQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>Click here to join this action<\/u><\/strong><\/a>]. There is no cost or obligation to you.<\/p>\n<p align=\"start\">About Johnson Fistel, LLP: <br \/> Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gIknayt5yR7PkvUIaz4u8Ob46t1_pqijNc9-BiKGXPmXyXQJK0FbeJC4GP3Ws2fdY0GPYV9AXN_R3gNije7Fo0etw1c70wHox1osMddYitPKHxdL01Cuf0NxrvyeelXB-RCYn0FQMKeAJSmHt_0D7b0ckymnQSNnZ5i7W9Lh6mljcvN6JnVpbGeby3YohzJNqQH3JBifw8_XEQcuSyvn5evLABZsFdYWvzr30nTFr1le1g0Ct1dDszgKNcRPv-btzVKHKiJie6ZvVEpcWwnQOUkgadJy1rDUSLR8E0zXfpyOEQm9KliYS9SoQKIXoS4yXZ57GzHKHd5ADELMcQGf6PpnDXB7I7iR79B97Shw34izwQiPClqISR0BR35U6R9LFOAj8o_Lo4D1BfWqGua1fMT_wz3knKX8tp0jJp9AV6yQecoAl65YKulYEDl8QPUxSynasXDq37CN8FC-W1b_YA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>https:\/\/www.johnsonfistel.com<\/u><\/a>. Attorney advertising. Past results do not guarantee future outcomes.<\/p>\n<p align=\"start\">Contact: <br \/> Johnson Fistel, LLP <br \/> Jim Baker, <u>619-814-4471<\/u><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HTZmyD6jYgW8eiaz_U9slJCxSjLJ6-4wrI18frvTHO15toKFUdkv0HzJ8_8Wm-i4K3YW_osg1VPh5f80knvhuHewKi3b_V297ZDZxSM3chk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>jimb@johnsonfistel.com<\/u><\/a><\/p>\n<p align=\"start\">[<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_qlav5TEXtmBN8tHNAUyEvt-ftSHDCp7DiRgb39DgmavL7yljGwA1IjU11zop0C509kW9A9ssAee1Lk0d9mWZ-HmX15a0sXunki4njmQOrchoYGCB_SnbJ7Hg_lSqFD7Tbdf_b5al0lToEnlKLjedA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>Click here to join this action<\/u><\/strong><\/a>]<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/61d6392d-4ba5-4e66-bfcf-69bfd144e491\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Dec. 18, 2020 (GLOBE NEWSWIRE) &#8212; Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT)\u00a0breached their fiduciary duties in connection with the proposed sale of the Company to Royal Philips (NYSE: PHG, AEX: PHIA). On December 18, 2020, BioTelemetry announced that it had entered into a definitive merger agreement with Royal Philips. Under the terms of the acquisition agreement, the Company&#8217;s shareholders will receive $72.00 per share in cash. The investigation concerns whether the BioTelemetry board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for BioTelemetry &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403181","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price? - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price? - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Dec. 18, 2020 (GLOBE NEWSWIRE) &#8212; Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT)\u00a0breached their fiduciary duties in connection with the proposed sale of the Company to Royal Philips (NYSE: PHG, AEX: PHIA). On December 18, 2020, BioTelemetry announced that it had entered into a definitive merger agreement with Royal Philips. Under the terms of the acquisition agreement, the Company&#8217;s shareholders will receive $72.00 per share in cash. The investigation concerns whether the BioTelemetry board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for BioTelemetry &hellip; Continue reading &quot;(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-19T00:09:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?\",\"datePublished\":\"2020-12-19T00:09:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/\"},\"wordCount\":308,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/\",\"name\":\"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price? - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=\",\"datePublished\":\"2020-12-19T00:09:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price? - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/","og_locale":"en_US","og_type":"article","og_title":"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price? - Market Newsdesk","og_description":"SAN DIEGO, Dec. 18, 2020 (GLOBE NEWSWIRE) &#8212; Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT)\u00a0breached their fiduciary duties in connection with the proposed sale of the Company to Royal Philips (NYSE: PHG, AEX: PHIA). On December 18, 2020, BioTelemetry announced that it had entered into a definitive merger agreement with Royal Philips. Under the terms of the acquisition agreement, the Company&#8217;s shareholders will receive $72.00 per share in cash. The investigation concerns whether the BioTelemetry board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for BioTelemetry &hellip; Continue reading \"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-19T00:09:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?","datePublished":"2020-12-19T00:09:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/"},"wordCount":308,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/","name":"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price? - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=","datePublished":"2020-12-19T00:09:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzOCMzODg5NTE0IzIxODE3ODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beat-alert-johnson-fistel-investigates-proposed-sale-of-biotelemetry-is-72-a-fair-price-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403181"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403181\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}